![IJMS | Free Full-Text | Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide IJMS | Free Full-Text | Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide](https://pub.mdpi-res.com/ijms/ijms-21-03895/article_deploy/html/images/ijms-21-03895-ag.png?1592882314)
IJMS | Free Full-Text | Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide
![The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria for Interpreting the Pathogenicity of Genetic Variants - The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria for Interpreting the Pathogenicity of Genetic Variants -](https://image.slidesharecdn.com/hvp-160617054102/85/the-clingen-sequence-variant-interpretation-working-group-refining-criteria-for-interpreting-the-pathogenicity-of-genetic-variants-marc-greenblatt-3-320.jpg?cb=1668023633)
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria for Interpreting the Pathogenicity of Genetic Variants -
![Best practices for the interpretation and reporting of clinical whole genome sequencing | npj Genomic Medicine Best practices for the interpretation and reporting of clinical whole genome sequencing | npj Genomic Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41525-022-00295-z/MediaObjects/41525_2022_295_Fig1_HTML.png)
Best practices for the interpretation and reporting of clinical whole genome sequencing | npj Genomic Medicine
![Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC ... Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC ...](https://ars.els-cdn.com/content/image/1-s2.0-S1098360022000016-gr2.jpg)
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC ...
![The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practice - ScienceDirect The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1098360022007031-fx1.jpg)
The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practice - ScienceDirect
![Assessing Variants in a Known Gene: Clinical Variant Classification and Use of the ClinGen Variant Curation Interface - ClinGen | Clinical Genome Resource Assessing Variants in a Known Gene: Clinical Variant Classification and Use of the ClinGen Variant Curation Interface - ClinGen | Clinical Genome Resource](https://clinicalgenome.org/site/assets/files/7786/debritter_hgsc_image.600x600.jpg)
Assessing Variants in a Known Gene: Clinical Variant Classification and Use of the ClinGen Variant Curation Interface - ClinGen | Clinical Genome Resource
![Schematic view of the clinical variant interpretation process. In a... | Download Scientific Diagram Schematic view of the clinical variant interpretation process. In a... | Download Scientific Diagram](https://www.researchgate.net/publication/370668576/figure/fig3/AS:11431281157437281@1683810597067/Schematic-view-of-the-clinical-variant-interpretation-process-In-a-human-protein-coding.png)
Schematic view of the clinical variant interpretation process. In a... | Download Scientific Diagram
![Dr. Christine Stanley: Face2Gene LABS at WuXi NextCODE: Phenotyping for Improved Variant Prioritization - FDNA™ Dr. Christine Stanley: Face2Gene LABS at WuXi NextCODE: Phenotyping for Improved Variant Prioritization - FDNA™](https://www.fdna.com/wp-content/uploads/2018/04/Screen-Shot-2018-04-18-at-11.41.06-AM.png)
Dr. Christine Stanley: Face2Gene LABS at WuXi NextCODE: Phenotyping for Improved Variant Prioritization - FDNA™
![The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practice - ScienceDirect The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1098360022007031-gr1.jpg)
The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practice - ScienceDirect
![Genomic Variant Analysis & Clinical Interpretation | Council of Scientific & Industrial Research | CSIR | GoI Genomic Variant Analysis & Clinical Interpretation | Council of Scientific & Industrial Research | CSIR | GoI](https://www.csir.res.in/sites/default/files/slider27-10-2020.jpg)
Genomic Variant Analysis & Clinical Interpretation | Council of Scientific & Industrial Research | CSIR | GoI
![Nothing's for sure, that's for sure: Evaluating variants of uncertain significance | Beyond the Ion Channel Nothing's for sure, that's for sure: Evaluating variants of uncertain significance | Beyond the Ion Channel](http://epilepsygenetics.net/wp-content/uploads/2016/08/Slide1.jpg)
Nothing's for sure, that's for sure: Evaluating variants of uncertain significance | Beyond the Ion Channel
![Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML | Cancer Genomics & Proteomics Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML | Cancer Genomics & Proteomics](https://cgp.iiarjournals.org/content/cgp/18/2/157/F1.large.jpg)
Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML | Cancer Genomics & Proteomics
![Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study - Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study -](https://www.thelancet.com/cms/attachment/6382992b-2bfa-4acf-b0ba-e2c062f15672/gr1_lrg.jpg)
Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study -
![Clinical DNA Variant Interpretation: Theory and Practice (Translational and Applied Genomics): 9780128205198: Medicine & Health Science Books @ Amazon.com Clinical DNA Variant Interpretation: Theory and Practice (Translational and Applied Genomics): 9780128205198: Medicine & Health Science Books @ Amazon.com](https://m.media-amazon.com/images/I/618k-c5rsaL._AC_UF1000,1000_QL80_.jpg)
Clinical DNA Variant Interpretation: Theory and Practice (Translational and Applied Genomics): 9780128205198: Medicine & Health Science Books @ Amazon.com
![Genes | Free Full-Text | Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules Genes | Free Full-Text | Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules](https://www.mdpi.com/genes/genes-12-00780/article_deploy/html/images/genes-12-00780-g007.png)
Genes | Free Full-Text | Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules
![CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer | Nature Genetics CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer | Nature Genetics](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fng.3774/MediaObjects/41588_2017_Article_BFng3774_Fig1_HTML.jpg)
CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer | Nature Genetics
![Clinical information can lead to finding a variant that might otherwise be missed - Blueprint Genetics Clinical information can lead to finding a variant that might otherwise be missed - Blueprint Genetics](https://blueprintgenetics.com/wp-content/uploads/2019/02/Infographic.jpg)
Clinical information can lead to finding a variant that might otherwise be missed - Blueprint Genetics
![Matching whole genomes to rare genetic disorders: Identification of potential causative variants using phenotype‐weighted knowledge in the CAGI SickKids5 clinical genomes challenge - Pal - 2020 - Human Mutation - Wiley Online Library Matching whole genomes to rare genetic disorders: Identification of potential causative variants using phenotype‐weighted knowledge in the CAGI SickKids5 clinical genomes challenge - Pal - 2020 - Human Mutation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8a31bf9b-d743-40d5-999c-0c2eaa7b75a6/humu23933-fig-0001-m.jpg)
Matching whole genomes to rare genetic disorders: Identification of potential causative variants using phenotype‐weighted knowledge in the CAGI SickKids5 clinical genomes challenge - Pal - 2020 - Human Mutation - Wiley Online Library
![Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory. | Semantic Scholar Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/dc56d1b633b43a8d5bf7b620bc05800989df591a/2-Figure1-1.png)